Interestingly, downregulation of OPA1 has been associated with both aberrant mitochondrial cristae remodeling and low energy production,53 and controlled transgenic overexpression of OPA1 can “tighten” cristae junctions, limiting cytochrome c release and providing protection from ischemic brain damage following stroke.54 The gene discussed is OPA1; the disease is Stroke.